Explain this page
Arphra AIPlain-English read on 22nd Century Group, Inc.’s valuationNo recent stories.
today
- 22nd Century Group, Inc. Highlights FDA Filing of VLN® MRTP Renewal Applications for Scientific Review41d
- 22nd Century Group, Inc. Highlights FDA Filing of VLN® MRTP Renewal Applications for Scientific Review41d
- 22nd Century Group Reports First Quarter 2026 Financial Results46d
- 22nd Century Group to Announce First Quarter 2026 Results on May 7, 202649d
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $1,237.50 (+27461.25%)
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.34% | -21.37% | -62.40% | -93.71% | -98.38% | -98.06% | -99.82% | -100.00% | -100.00% | -100.00% | -100.00% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$4.47
Bid
$4.00
177 sh
Ask
$4.54
37 sh
Spread
$0.540
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Real Estate+1.28%
- Industrials+1.01%
- Basic Materials+0.65%
- Energy+0.59%
- Healthcare+0.03%
- Utilities-0.09%
- Financial Services-0.18%
- Communication Services-0.56%
- Technology-0.77%
- Consumer Cyclical-0.83%
- Consumer Defensive-0.98%
Top industries (issuer's industry highlighted)
- Tobacco-1.97%
- Biotechnology+6.56%
- Financial - Mortgages-4.05%
- Electrical Equipment & Parts+3.88%
- Staffing & Employment Services-3.62%
- Software - Services-3.30%
- Software - Infrastructure-3.07%
- Advertising Agencies+2.92%
- Apparel - Footwear & Accessories-2.80%
- Engineering & Construction+2.80%
- Financial - Conglomerates+2.62%
- Luxury Goods+2.47%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- 22nd Century Group, Inc. Highlights FDA Filing of VLN® MRTP Renewal Applications for Scientific Reviewglobenewswire.com·May 12, 2026
- 22nd Century Group, Inc. Highlights FDA Filing of VLN® MRTP Renewal Applications for Scientific Reviewglobenewswire.com·May 12, 2026
- 22nd Century Group Reports First Quarter 2026 Financial Resultsglobenewswire.com·May 07, 2026
- 22nd Century Group to Announce First Quarter 2026 Results on May 7, 2026globenewswire.com·May 04, 2026
- 22nd Century Group to Announce First Quarter 2026 Results on May 7, 2026globenewswire.com·May 04, 2026
Peers
No peer list available for XXII.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|